Victory Capital Management
RVLP

Victory Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Victory Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,682
Closed -$14K – 3465
2020
Q1 		$14K Buy
+4,682
New +$24.9K ﹤0.01% 3233
2019
Q4 		– Sell
-1,687
Closed -$6K – 3451
2019
Q3 		$6K Buy
+1,687
New +$5.71K ﹤0.01% 3427

Other funds holding RVLP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Victory Capital Management's RVLP Position: Q2 2020 in Review

Victory Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2020, closing a stake of 4,682 shares — an estimated $14K sold.

Victory Capital Management first reported a position in RVLP in Q3 2019 and held it in 2 quarters. The position peaked at $14K in Q1 2020. 66 funds tracked by Wall St. Rank hold RVLP as of Q2 2020.

  • Victory Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 4,682 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2020, an estimated $14K.
  • Victory Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $14K in Q1 2020.
  • 66 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.